Launch week offerEnds in00h00m00s

annual Promonthly Pro

Suzanne McCluskey

Has grant

Massachusetts General Hospital

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Recent Grants

Grant: Open

Exploring low-level HIV viremia among individuals on dolutegravir in sub-Saharan Africa (Low-V Africa Study)

Open Date: 2025-09-19

Close Date: 2030-08-31

Grant: Open

A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure for Individuals on TLD in Sub-Saharan Africa

Open Date: 2022-07-01

Close Date: 2027-06-30

Grant: Close

A urine tenofovir immunoassay to distinguish adherence versus resistance-based HIV treatment failure

Open Date: 2019-04-16

Close Date: 2023-03-31

Grant: Close

Virologic and pharmacologic determinants of dolutegravir failure in East Africa

Open Date: 2018-12-10

Close Date: 2024-07-10

Articles (19)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Paul Revill

Professor and Head of Global Health Team

University of York

UNITED KINGDOM

View details

Roger D Kouyos

Associate Professor

University Hospital of Zurich

SWITZERLAND

View details

Mahomed Yunus Moosa

Head of Department

University of KwaZulu-Natal

SOUTH AFRICA

View details

Richard Lessells

Senior Infectious Diseases Specialist

University of KwaZulu-Natal

SOUTH AFRICA

View details

Gavin George

Programme Leader

University of KwaZulu-Natal

SOUTH AFRICA

View details

Guinevere Q Lee

Assistant Professor

Weill Cornell Medicine

UNITED STATES

View details

Valentina Cambiano

Associate Professor

University College London

UNITED KINGDOM

View details

Robert W. Shafer

Stanford University

UNITED STATES

View details

Matthew Spinelli

UCSF Medical Center

UNITED STATES

View details

David van de Vijver

Associate professor

Erasmus University Rotterdam

NETHERLANDS

View details

Andrew Hill

University of Liverpool

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Suzanne McCluskey

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (19)

Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence

Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa

The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling study.

Virologic Failure and Emergent Integrase Strand Transfer Inhibitor Drug Resistance With Long-Acting Cabotegravir for HIV Treatment: A Meta-analysis

The impact of adherence counseling incorporating a point of care urine tenofovir assay on virologic suppression among individuals failing tenofovir-lamivudine-dolutegravir: A pre-post intervention study

Evaluating the Efficacy of Crushed Bictegravir/Emtricitabine/Tenofovir Alafenamide Administered via Tube

Factors Associated With Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda

Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis

Predictors of treatment-emergent resistance to dolutegravir

Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Uganda

Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review

Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results

Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis

Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa

Risk of Emergent Dolutegravir Resistance Mutations In People Living With HIV: A Rapid Scoping Review

Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in Africa

Seemingly Unrelated Regression Analysis of the Cost and Health-Related Quality of Life Outcomes of the REVAMP Randomized Clinical Trial

Is it time to make 'undetectable for all' the global standard for HIV care?

Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure

Collaborators (11)

Paul Revill

Roger D Kouyos

Mahomed Yunus Moosa

Richard Lessells

Gavin George

Guinevere Q Lee

Valentina Cambiano

Robert W. Shafer

Matthew Spinelli

David van de Vijver

Andrew Hill

Make your next move.